Literature DB >> 19686817

Dysoxylum binectariferum Hook.f (Meliaceae), a rich source of rohitukine.

Patel Mohanakumara1, Nambiar Sreejayan, Vaidayanathan Priti, Bheemanahally Thimmappa Ramesha, Gudasalamani Ravikanth, Kotiganahalli Narayanagowda Ganeshaiah, Ramesh Vasudeva, John Mohan, Thankayyan Retnabai Santhoshkumar, Prabhu Dutt Mishra, Viswakarma Ram, Ramanan Uma Shaanker.   

Abstract

Rohitukine, a chromane alkaloid, is a precursor of flavopiridol, a promising anti-cancer compound. Currently in Phase III clinical trials, flavopiridol is a potent inhibitor of several cyclin-dependent kinases (CDKs). Rohitukine was first reported from Amoora rohituka (0.083% dry weight) followed by that in Dysoxylum binectariferum (0.9% dry weight), both belonging to the family Meliaceae. Here, we report incredibly high yields of rohitukine (7% dry weight) in trees of D. binectariferum from the Western Ghats, India. Crude extracts of the tree were found to be highly effective against ovarian and breast cancer lines tested. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19686817     DOI: 10.1016/j.fitote.2009.08.010

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  8 in total

1.  Pharmacological evaluation of the efficacy of Dysoxylum binectariferum stem bark and its active constituent rohitukine in regulation of dyslipidemia in rats.

Authors:  Sunil K Mishra; Shashi Tiwari; Shishir Shrivastava; Ravi Sonkar; Vaibhav Mishra; Sunil K Nigam; Anil K Saxena; Gitika Bhatia; Snober S Mir
Journal:  J Nat Med       Date:  2014-03-28       Impact factor: 2.343

Review 2.  Emerging drug profile: cyclin-dependent kinase inhibitors.

Authors:  James S Blachly; John C Byrd
Journal:  Leuk Lymphoma       Date:  2013-07-29

3.  5-Hy-droxy-7-meth-oxy-2-methyl-4H-chromen-4-one from Dysoxylum macrocarpum (Meliaceae).

Authors:  Ibrahim A Najmuldeen; Abdul Hamid Abdul Hadi; Khalijah Awang; Khalit Mohamad; Seik Weng Ng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-07-03

4.  Cytotoxic and apoptotic inducing activity of Amoora rohituka leaf extracts in human breast cancer cells.

Authors:  Rajesh Kumar Singh; Amit Ranjan; Akhileshwar Kumar Srivastava; Monika Singh; Anil Kumar Shukla; Neelam Atri; Anurag Mishra; Anil Kumar Singh; Santosh Kumar Singh
Journal:  J Ayurveda Integr Med       Date:  2019-03-04

5.  The Chromone Alkaloid, Rohitukine, Affords Anti-Cancer Activity via Modulating Apoptosis Pathways in A549 Cell Line and Yeast Mitogen Activated Protein Kinase (MAPK) Pathway.

Authors:  Mohd Kamil; Pooja Jadiya; Saba Sheikh; Ejazul Haque; Aamir Nazir; Vijai Lakshmi; Snober S Mir
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

6.  Desorption Electrospray Ionization (DESI) Mass Spectrometric Imaging of the Distribution of Rohitukine in the Seedling of Dysoxylum binectariferum Hook. F.

Authors:  Patel Mohana Kumara; Amitava Srimany; Suganya Arunan; Gudasalamani Ravikanth; Ramanan Uma Shaanker; Thalappil Pradeep
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

7.  Cell cycle regulation and anticancer drug discovery.

Authors:  Jingwen Bai; Yaochen Li; Guojun Zhang
Journal:  Cancer Biol Med       Date:  2017-11       Impact factor: 4.248

8.  Selection of a Water-Soluble Salt Form of a Preclinical Candidate, IIIM-290: Multiwell-Plate Salt Screening and Characterization.

Authors:  Vikas Kumar; Sandip B Bharate; Ram A Vishwakarma; Sonali S Bharate
Journal:  ACS Omega       Date:  2018-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.